057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs. (12th April 2019)

Record Type:: Journal Article
Title:: 057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs. (12th April 2019)
Main Title:: 057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs
Authors:: van Vollenhoven, R
Dore, R
Chen, K
Camp, H S
Enejosa, J
Shaw, T
Suboticki, J L
Hall, S
Abstract:
Is Part Of:: Rheumatology. Volume 58(2019)Supplement 3
Journal:: Rheumatology
Issue:: Volume 58(2019)Supplement 3
Issue Display:: Volume 58, Issue 3 (2019)
Year:: 2019
Volume:: 58
Issue:: 3
Issue Sort Value:: 2019-0058-0003-0000
Page Start:
Page End:
Publication Date:: 2019-04-12
Subjects:: Rheumatism -- Periodicals
Rheumatology -- Periodicals
616.723005
Journal URLs:: http://rheumatology.oupjournals.org ↗
http://rheumatology.oxfordjournals.org ↗
http://ukcatalogue.oup.com/ ↗
http://firstsearch.oclc.org ↗
DOI:: 10.1093/rheumatology/kez106.056 ↗
Languages:: English
ISSNs:: 1462-0324
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 7960.731900
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 11800.xml